News

Published on 23 Jan 2025 on Insider Monkey · via Yahoo Finance

Why Vir Biotechnology, Inc. (VIR) Is Skyrocketing Now


Article preview image

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we...

NASDAQ.VIR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Vir Biotechnology, Inc. (VIR) Is Skyrocketing Now

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article,...

Insider Monkey · via Yahoo Finance 23 Jan 2025

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its...

Benzinga · via AOL 11 Jan 2025

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its...

Benzinga · via Yahoo Finance 10 Jan 2025

Johnson&Johnson, UnitedHealth lead Thursday's market cap stock movers By...

Johnson&Johnson, UnitedHealth lead Thursday's market cap stock movers

Investing.com 10 Jan 2025

Vir Biotechnology Reports Promising Trial Results for Cancer Therapies

Vir Biotechnology ( (VIR) ) has issued an update. Vir Biotechnology announced promising Phase 1...

TipRanks · via Yahoo Finance 9 Jan 2025

VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

Vir Biotechnology posts encouraging initial data from phase I studies evaluating VIR-5818 and...

Zacks · via Yahoo Finance 9 Jan 2025

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other...

U.S. stocks were lower, with the Dow Jones index falling over 150 points on Wednesday. Shares of ...

Benzinga 8 Jan 2025

Vir Biotechnology stock soars on promising trial data By Investing.com

Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) surged 29% following the release of encouraging...

Investing.com 8 Jan 2025

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic...

Vir Biotechnology Inc (VIR) reports increased R&D expenses due to the Sanofi transaction, while...

GuruFocus.com · via Yahoo Finance 2 Nov 2024

State Street Corp's Strategic Acquisition in Vir Biotechnology Inc

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio ...

GuruFocus.com · via Yahoo Finance 18 Oct 2024